Drug intelligence / Profile preview

RH5.1 + Matrix-M (University of Oxford)

Development stage
Unknown
Lead developer
University of Oxford
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Administration
Intramuscular
01

Overview

RH5.1 + Matrix-M is a recombinant protein subunit vaccine candidate designed to prevent malaria caused by *Plasmodium falciparum*. The vaccine consists of RH5.1, a soluble recombinant version of the highly conserved parasite protein Reticulocyte-binding protein Homolog 5 (RH5), formulated with Novavax's saponin-based adjuvant, Matrix-M. RH5 is essential for the invasion of human red blood cells by the malaria parasite; the vaccine aims to elicit high titers of neutralizing antibodies that block this invasion process. Developed by the University of Oxford's Jenner Institute, the vaccine has undergone clinical testing in both malaria-naive adults and malaria-endemic populations, including infants, to assess safety, immunogenicity, and efficacy against blood-stage infection.

Other names
RH5.1/Matrix-MRH5.1 soluble protein in Matrix-MRH-5.1 soluble protein in Matrix-MRH 5.1 soluble protein in Matrix-M
02

Targets

PfRH5

Beyond the preview

Go deeper on RH5.1 + Matrix-M (University of Oxford).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RH5.1 + Matrix-M (University of Oxford).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call